Metoprolol Medical Valley

Metoprolol, the active ingredient in Metoprolol Medical Valley, is a beta blocker presented as a tablet for oral use. It treats hypertension, angina pectoris, myocardial infarction, heart failure and cardiac arrhythmias in adult patients. GNH USA supplies Metoprolol Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol is a selective β1‑adrenergic blocker used in cardiovascular conditions.

Hypertension: lowers blood pressure by reducing cardiac output and renin release. Angina pectoris: decreases myocardial oxygen demand through heart‑rate reduction. Myocardial infarction: improves post‑MI survival by limiting arrhythmias and workload. Heart failure: reduces morbidity and mortality in chronic systolic failure. Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

Metoprolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue - Dizziness - Bradycardia - Gastrointestinal upset

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with reactive airway disease

Before initiating therapy, clinicians should consider several safety measures.

Monitor blood pressure: check regularly to ensure therapeutic control. Assess heart rate: watch for bradycardia, particularly in patients with conduction disorders. Use caution in asthma or COPD: β1‑selectivity may still affect bronchial tone. Adjust dose in renal impairment: reduced clearance may require lower dosing. Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Metoprolol can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia. - Verapamil or diltiazem: increased risk of AV block. - Antidiabetic agents: may mask hypoglycaemia symptoms. - MAO inhibitors: enhanced hypotensive effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering. - NSAIDs: may reduce antihypertensive efficacy. - Digoxin: potential increase in serum digoxin levels.